EASTERN COOPERATIVE ONCOLOGY GROUP
东方肿瘤合作组
基本信息
- 批准号:3555874
- 负责人:
- 金额:$ 22.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-12-01 至 1989-04-30
- 项目状态:已结题
- 来源:
- 关键词:Hodgkin's disease alkaline phosphatase breast neoplasms carmustine cholesterol esters combination cancer therapy cooperative study cyclophosphamide drug administration routes drug metabolism estrogens fluorouracil gastrointestinal neoplasms head /neck neoplasm hormone binding protein hormone receptor human subject human therapy evaluation hydrazines hypercalcemia immunofluorescence technique immunologic skin test information dissemination isozymes kidney neoplasms lung neoplasms lymphoma medroxyprogesterone melanoma metastasis mithramycin mitomycin C multiple myeloma mycosis fungoides lymphoma neoplasm /cancer chemotherapy neoplasm /cancer immunodiagnosis neoplasm /cancer immunotherapy neoplasm /cancer radiation therapy neoplasm /cancer surgery prednisone prostate neoplasms psychological stressor skin neoplasms streptozotocin surface antigens testis neoplasms tumor antigens
项目摘要
This application requests continued support for the Tufts University
Oncology Program to participate in the Eastern Cooperative Oncology Group.
There are now 16 hospitals affiliated with New England Medical Center to
form the Tufts Network, organized specifically to participate in
multi-modality clinical trials. As a member of ECOG for more than
20\years, Tufts continues to provide stable leadership which encourages and
facilitates patient accrual. ECOG investigators at Tufts are active in
several laboratory and in-house clinical projects which will form the basis
for future ECOG protocols. Sixteen Tufts network members serve on 13 ECOG
disease, modality and standing steering committees. Over the past two
years, Tufts Investigators have chaired 15 active or proposed ECOG studies.
Tufts nurse oncologists participated in writing the drug administration
sections of recent protocols and contributed to writing the Nursing Drug
Information Handbook. A comprehensive data management system provides
timely, accurate data collection, verified by institutional audits and
central computerized delinquency monitoring.
Long term goals of the Tufts Oncology Program are to increase protocol
development in all treatment modalities; to translate basic science
projects currently underway into ECOG protocols; to increase patient
accrual on ECOG studies; to further develop and refine the data management
system and to educate physicians, other medical personnel and the public
about cancer clinical trials and current cancer treatment.
此申请要求继续支持塔夫茨大学
肿瘤学计划参加东部肿瘤协作组。
现在有16家附属于新英格兰医疗中心的医院,
形成塔夫茨网络,专门组织参加
多模态临床试验。 作为ECOG的成员,
20年来,塔夫茨继续提供稳定的领导,鼓励和
有利于患者的增加。 塔夫茨大学的ECOG研究人员积极参与
几个实验室和内部临床项目,将形成基础
用于未来的ECOG方案。 16名塔夫茨网络成员在13个西非经济共同体中任职
疾病、方式和常设指导委员会。 过去两
多年来,塔夫茨大学的研究人员主持了15项正在进行或拟议中的ECOG研究。
塔夫茨大学的肿瘤学家护士参与撰写了药物管理
最近方案的部分,并为撰写护理药物做出了贡献
信息手册。 全面的数据管理系统提供
及时、准确的数据收集,并通过机构审计进行验证,
中央计算机犯罪监控系统
塔夫茨肿瘤学项目的长期目标是增加方案
所有治疗方式的发展;将基础科学
目前正在进行的项目纳入ECOG方案;以增加患者
ECOG研究的累积;进一步开发和完善数据管理
教育医生、其他医务人员和公众
关于癌症临床试验和目前的癌症治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS JAMES. SMITH其他文献
THOMAS JAMES. SMITH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS JAMES. SMITH', 18)}}的其他基金
PHASE III RANDOMIZED CROSS-OVER STUDY USING NEBULIZED FENTANYL FOR DYSPNEA
使用芬太尼雾化治疗呼吸困难的 III 期随机交叉研究
- 批准号:
7375149 - 财政年份:2005
- 资助金额:
$ 22.54万 - 项目类别:
相似海外基金
The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
- 批准号:
10220574 - 财政年份:2021
- 资助金额:
$ 22.54万 - 项目类别:
Post-Transcriptional Processing of the Small Intestinal Alkaline Phosphatase in the Postnatal Developing Pig
产后发育猪小肠碱性磷酸酶的转录后加工
- 批准号:
RGPIN-2016-05827 - 财政年份:2021
- 资助金额:
$ 22.54万 - 项目类别:
Discovery Grants Program - Individual
The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
- 批准号:
10413987 - 财政年份:2021
- 资助金额:
$ 22.54万 - 项目类别:
The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
- 批准号:
10601067 - 财政年份:2021
- 资助金额:
$ 22.54万 - 项目类别:
Dietary induction of intestinal alkaline phosphatase intended to detoxify endotoxin and analysis of its mechanism of action.
膳食诱导肠道碱性磷酸酶解毒内毒素及其作用机制分析。
- 批准号:
20K05936 - 财政年份:2020
- 资助金额:
$ 22.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Selective targeting of human alkaline phosphatase isozymes
选择性靶向人碱性磷酸酶同工酶
- 批准号:
10359823 - 财政年份:2020
- 资助金额:
$ 22.54万 - 项目类别:
Functional analysis of alkaline phosphatase, a stem cell marker, using human deciduous dental pulp cells derived from the patient with Hypophosphatasia (HPP)
使用源自低磷酸酯酶症 (HPP) 患者的人乳牙牙髓细胞对干细胞标记物碱性磷酸酶进行功能分析
- 批准号:
20K10210 - 财政年份:2020
- 资助金额:
$ 22.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding the role of tissue non-specific alkaline phosphatase in osteogenesis for the therapy of hypophosphatasia.
了解组织非特异性碱性磷酸酶在成骨作用中的作用,以治疗低磷酸酯酶症。
- 批准号:
20K16894 - 财政年份:2020
- 资助金额:
$ 22.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Selective targeting of human alkaline phosphatase isozymes
选择性靶向人碱性磷酸酶同工酶
- 批准号:
10117265 - 财政年份:2020
- 资助金额:
$ 22.54万 - 项目类别:
Post-Transcriptional Processing of the Small Intestinal Alkaline Phosphatase in the Postnatal Developing Pig
产后发育猪小肠碱性磷酸酶的转录后加工
- 批准号:
RGPIN-2016-05827 - 财政年份:2020
- 资助金额:
$ 22.54万 - 项目类别:
Discovery Grants Program - Individual